|
|
Volumn 126, Issue 11, 1997, Pages 917-918
|
|
High-dose chemotherapy for breast cancer [4] (multiple letters)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
FLUOROURACIL;
THIOTEPA;
VINBLASTINE;
ANTINEOPLASTIC AGENT;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
BREAST CANCER;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFICACY;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LETTER;
MAJOR CLINICAL STUDY;
MEDICAL ETHICS;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
ADJUVANT CHEMOTHERAPY;
BREAST TUMOR;
NOTE;
CONTROLLED CLINICAL TRIAL;
METHODOLOGY;
NETHERLANDS;
RANDOMIZED CONTROLLED TRIAL;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
ETHICS, MEDICAL;
FEMALE;
HUMANS;
NETHERLANDS;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
UNITED STATES;
|
|
EID: 0031009886
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-126-11-199706010-00021 Document Type: Letter |
|
Times cited : (5)
|
|
References (0)
|
